Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care
Fangzhou has been named to the KPMG China Healthcare 50 list, in recognition of its deep expertise in AI-driven chronic disease management.
Fangzhou has been named to the KPMG China Healthcare 50 list, in recognition of its deep expertise in AI-driven chronic disease management.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.